12-1844466-G-T
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PVS1PP5
The NM_172364.5(CACNA2D4):c.2406C>A(p.Tyr802*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000848 in 1,613,336 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. Y802Y) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_172364.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA2D4 | ENST00000382722.10 | c.2406C>A | p.Tyr802* | stop_gained | Exon 25 of 38 | 1 | NM_172364.5 | ENSP00000372169.4 | ||
CACNA2D4 | ENST00000586184.5 | c.2406C>A | p.Tyr802* | stop_gained | Exon 25 of 37 | 5 | ENSP00000465060.1 | |||
CACNA2D4 | ENST00000587995.5 | c.2331C>A | p.Tyr777* | stop_gained | Exon 24 of 37 | 5 | ENSP00000465372.1 | |||
CACNA2D4 | ENST00000585708.5 | c.2214C>A | p.Tyr738* | stop_gained | Exon 25 of 37 | 5 | ENSP00000467697.1 | |||
CACNA2D4 | ENST00000588077.5 | c.2214C>A | p.Tyr738* | stop_gained | Exon 25 of 38 | 5 | ENSP00000468530.1 | |||
CACNA2D4 | ENST00000444595.6 | n.*652C>A | non_coding_transcript_exon_variant | Exon 25 of 37 | 1 | ENSP00000403371.2 | ||||
CACNA2D4 | ENST00000537784.5 | n.246C>A | non_coding_transcript_exon_variant | Exon 3 of 15 | 1 | ENSP00000440231.2 | ||||
CACNA2D4 | ENST00000444595.6 | n.*652C>A | 3_prime_UTR_variant | Exon 25 of 37 | 1 | ENSP00000403371.2 |
Frequencies
GnomAD3 genomes AF: 0.000539 AC: 82AN: 152202Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000408 AC: 101AN: 247676 AF XY: 0.000372 show subpopulations
GnomAD4 exome AF: 0.000880 AC: 1286AN: 1461134Hom.: 0 Cov.: 30 AF XY: 0.000872 AC XY: 634AN XY: 726754 show subpopulations
GnomAD4 genome AF: 0.000539 AC: 82AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.000457 AC XY: 34AN XY: 74364 show subpopulations
ClinVar
Submissions by phenotype
Retinal cone dystrophy 4 Pathogenic:2
- -
- -
not provided Pathogenic:1Uncertain:1
This sequence change creates a premature translational stop signal (p.Tyr802*) in the CACNA2D4 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in CACNA2D4 cause disease. This variant is present in population databases (rs71454844, gnomAD 0.08%), and has an allele count higher than expected for a pathogenic variant. This premature translational stop signal has been observed in individual(s) with CACNA2D4-related conditions (PMID: 17033974, 36460718). ClinVar contains an entry for this variant (Variation ID: 2504). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 17033974, 26218913, 31980526, 32967234, 32607809) -
CACNA2D4-related disorder Pathogenic:1
The CACNA2D4 c.2406C>A variant is predicted to result in premature protein termination (p.Tyr802*). This variant has been reported in the homozygous state in two siblings with a mild, progressive cone dystrophy; it was found to be heterozygous in an unaffected parent and absent from two additional unaffected siblings (Wycisk et al. 2006. PubMed ID: 17033974). This variant has also been reported in an individual with an inherited retinal disease as part of a genetically solved cohort, although no additional details were provided (Table S1, Karali et al. 2022. PubMed ID: 36460718). This variant is reported in 0.078% of alleles in individuals of European (non-Finnish) descent in gnomAD. Nonsense variants in CACNA2D4 are expected to be pathogenic. This variant is interpreted as likely pathogenic. -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at